Headache News and Research

Latest Headache News and Research

West Nile virus case in court in Canada

Just as the first mosquitoes are appearing in parts of the United States carrying the West Nile virus, a court in Canada has ruled that an insurance company must pay a man compensation after he was bitten by a mosquito at work and developed the West Nile virus.

15 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

Abbott seeks U.S. and E.U. approvals for Humira as a treatment for juvenile rheumatoid arthritis

Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the U.S. Food and Drug Administration (FDA) and a Type II Variation to the European Medicines Agency (EMEA) seeking approval to market HUMIRA (adalimumab) as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and juvenile idiopathic arthritis (JIA) in the European Union (EU).

9 May 2007

New treatments for brain hemorrhage

The first scientifically proven treatments for intracerebral hemorrhage, or "bleeding," strokes, are on the horizon, including a new drug that holds promise for slowing bleeding and limiting brain damage resulting from such a stroke, according to updated American Heart Association/American Stroke Association guidelines.

4 May 2007

Migraines may be sign of post-traumatic stress for Iraq veterans

Soldiers returning from combat in Iraq who have migraine headaches are more than twice as likely to also have symptoms of post-traumatic stress, depression or anxiety than soldiers who do not have migraines, according to research presented at the American Academy of Neurology's 59th Annual Meeting in Boston.

4 May 2007

Renewal of Echinacea and St John's Wort research

A five-year-old research center dedicated to understanding and improving Echinacea and Hypericum perforatum (St. John's wort) has received $4.4 million in continuation funding from the National Institutes of Health. The renewal is for three years.

4 May 2007

Reclast found to cause abnormal heart rhythms

An osteoporosis drug with the potential to cut the risk of spine fractures by 70 percent and the chance of hip fractures by 41 percent, has been found to have an adverse side effect on some women.

3 May 2007

1758 cases of malaria reported in UK travellers in 2006

1386 of the cases were due to the potentially fatal Plasmodium falciparum which is a major international health risk and which kills more than a million people a year in Africa. 219 were due to Plasmodium vivax which causes a debilitating disease, but is rarely fatal.

2 May 2007

Levosimendan compared to dobutamine for decompensated heart failure

The drug levosimendan did not improve survival for patients with decompensated heart failure when compared with a more widely-used treatment for this condition, dobutamine, according to a study in the May 2 issue of JAMA.

2 May 2007

Teenagers who suffer migraines at risk of suicide

Researchers in Taiwan say teens who suffer from migraine headaches on a daily basis, are at greater risk for suicide than teens who don't have migraines.

2 May 2007

Migraine sufferers may have form of brain damage

Scientists in the U.S. are suggesting that people with migraines may also be suffering from some form of brain damage.

2 May 2007

Teens who have chronic daily headaches are at greater risk for suicide

Teens who have chronic daily headache, especially those with migraine headaches, are at greater risk for suicide than teens who don't have migraines, according to a study published in the May 1, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.

1 May 2007

Tai Chi may help alleviate tension headaches

FINDINGS : Researchers found that Tai Chi, a traditional Chinese low-impact mind-body exercise, provided significant health benefits for adults suffering from tension headaches

30 Apr 2007

Headaches may act like tiny transient strokes

Migraines may be doing more than causing people skull-splitting pain. Scientists have found evidence that the headaches may also be acting like tiny transient strokes, leaving parts of the brain starved for oxygen and altering the brain in significant ways.

30 Apr 2007

A need to assess risks involved with spinal manipulation in children

Researchers are calling for the creation of a collaborative registry to assess the risk of serious injuries when treating children using spinal manipulation.

27 Apr 2007

Neuromed licenses chronic pain product from ALZA Corporation

Neuromed Pharmaceuticals has announced that it has licensed from ALZA Corporation the exclusive U.S. rights to develop and commercialize OROS(R) Hydromorphone, an extended release formulation of a potent opioid analgesic in Phase 3 clinical development.

25 Apr 2007

Researchers want to learn if heart defect 'at heart' of some migraines

Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.

21 Apr 2007

Jefferson researchers study whether common heart defect may cause of some forms of migraine headaches

Researchers of the heart and headaches at Thomas Jefferson University Hospital are combining efforts to determine if a common heart defect may be the cause of some forms of migraine headaches.

20 Apr 2007

FDA approves new bird flu vaccine from sanofi pasteur

The U.S. Food and Drug Administration (FDA) has announced the first approval in the United States of a vaccine for humans against the H5N1 influenza virus, commonly known as avian or bird flu.

18 Apr 2007

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Bristol-Myers Squibb Company has announced new results of the Baraclude (entecavir) resistance monitoring program, which found a continued low incidence of resistance in studies of nucleoside-naive chronic hepatitis B patients through four years of treatment.

16 Apr 2007